A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Clinical trial NCT04762069 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04762069
- Sponsor
- CNS Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-18
- Primary completion
- 2026-04-27
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.